Membrane-anchored peptide inhibits human immunodeficiency virus entry

J Virol. 2001 Mar;75(6):3038-42. doi: 10.1128/JVI.75.6.3038-3042.2001.

Abstract

Peptides derived from the heptad repeats of human immunodeficiency virus (HIV) gp41 envelope glycoprotein, such as T20, can efficiently inhibit HIV type 1 (HIV-1) entry. In this study, replication of HIV-1 was inhibited more than 100-fold in a T-helper cell line transduced with a retrovirus vector expressing membrane-anchored T20 on the cell surface. Inhibition was independent of coreceptor usage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Cell Line
  • Cell Membrane / metabolism
  • Enfuvirtide
  • Genetic Vectors
  • HIV Envelope Protein gp41 / chemistry
  • HIV Envelope Protein gp41 / genetics
  • HIV Envelope Protein gp41 / metabolism
  • HIV Envelope Protein gp41 / physiology*
  • HIV-1 / physiology*
  • Humans
  • Molecular Sequence Data
  • Peptide Fragments / chemistry
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism
  • Peptide Fragments / physiology*
  • Retroviridae / genetics
  • T-Lymphocytes, Helper-Inducer / virology*
  • Transduction, Genetic
  • Virus Replication

Substances

  • HIV Envelope Protein gp41
  • Peptide Fragments
  • Enfuvirtide